AFM-17

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAFM-17
Drug Alias NameCD6 antagonists (Affimed)anti CD-6 IgG antibody (Affimed)AFM-17
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionT-cell differentiation antigen CD6 inhibitors
TargetsT-cell differentiation antigen CD6
Therapy Area/IndicationsAutoimmune DiseasesMultiple MyelomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffimed Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffimed Nv
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesMultiple MyelomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A